title: The DEFINE study: a bright future for CETP inhibitors?
authors.forename: Niki
authors.initials: N
authors.lastname: Katsiki
authors.forename: Vasilios G
authors.initials: VG
authors.lastname: Athyros
authors.forename: Dimitri P
authors.initials: DP
authors.lastname: Mikhailidis
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors*; D008076:Cholesterol, HDL / Q000378:metabolism; D008078:Cholesterol, LDL / Q000378:metabolism; D050171:Dyslipidemias / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D023303:Oxazolidinones / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology*
chemical_list: D000924:Anticholesteremic Agents; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D023303:Oxazolidinones; D011804:Quinolines; C483909:torcetrapib; C530884:anacetrapib